TRDA

NASDAQStock

Entrada Therapeutics, Inc.

$12.60-0.39 (-2.97%)

52-Week Range

$5.02

$13.50

Key Stats

Market Cap

482.2M

P/E Ratio

—

Dividend Yield

—

Beta

-0.12

Volume

95.7K

Avg Volume

258.2K

Performance

+19.30%

+17.68%

+153.52%

YTD

+29.15%

+20.07%

-7.94%

-45.80%

Price Chart

ETF Exposure

TRDA is held by 54 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	46	$727	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,675	$26K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	8	$125	$337.7M	0.32%
VTHR	Vanguard Russell 3000 ETF	0.00%	1,999	$23K	$5.50B	0.06%

PreviousPage 2 of 2

About TRDA ETF Exposure

Entrada Therapeutics, Inc. (TRDA) is held by 54 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 482.2M, TRDA is a widely held institutional stock. The stock currently trades at $12.60. Investors can gain exposure to TRDA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TRDA, sorted by portfolio weight.